nafamostat has been researched along with Cryoglobulinemia in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Cryoglobulinemia: A condition characterized by the presence of abnormal quantities of CRYOGLOBULINS in the blood. Upon cold exposure, these abnormal proteins precipitate into the microvasculature leading to restricted blood flow in the exposed areas.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyata, T | 1 |
| Fujita, Y | 1 |
| Inagi, R | 1 |
| Inoue, I | 1 |
| Sugiyama, S | 1 |
| Maeda, K | 1 |
1 other study available for nafamostat and Cryoglobulinemia
| Article | Year |
|---|---|
Effectiveness of nafamostat mesilate on glomerulonephritis in immune-complex diseases.
Topics: Benzamidines; Complement Inactivator Proteins; Cryoglobulinemia; Glomerulonephritis; Guanidines; Hum | 1993 |